| Lactic acid bacteria isolated from yak milk show probiotic potential M Kaur, H Singh, M Jangra, L Kaur, P Jaswal, C Dureja, H Nandanwar, ... Applied microbiology and biotechnology 101, 7635-7652, 2017 | 48 | 2017 |
| Discovery of a small-molecule protein kinase Cδ-selective activator with promising application in colon cancer therapy C Bessa, J Soares, L Raimundo, JB Loureiro, C Gomes, F Reis, ... Cell death & disease 9 (2), 23, 2018 | 33 | 2018 |
| Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile AO Olaitan, C Dureja, MA Youngblom, MA Topf, WJ Shen, ... Nature Communications 14 (1), 4130, 2023 | 28 | 2023 |
| Phylogenetic Distribution and Prevalence of Genes Encoding Class I Integrons and CTX-M-15 Extended-Spectrum β-Lactamases in Escherichia coli Isolates from … C Dureja, S Mahajan, S Raychaudhuri PloS one 9 (11), e112551, 2014 | 27 | 2014 |
| Mechanisms and impact of antimicrobial resistance in Clostridioides difficile C Dureja, AO Olaitan, JG Hurdle Current opinion in microbiology 66, 63-72, 2022 | 26 | 2022 |
| Evidence on how a conserved glycine in the hinge region of HapR regulates its DNA binding ability: lessons from a natural variant M Dongre, N Santa Singh, C Dureja, N Peddada, AK Solanki, ... Journal of Biological Chemistry 286 (17), 15043-15049, 2011 | 22 | 2011 |
| VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model R Tripathi, S Singh Naorem, C Dureja, S Haldar, AK Mondal, ... Journal of medical microbiology 59 (1), 17-24, 2010 | 18 | 2010 |
| Identification of novel small RNAs in Burkholderia cenocepacia KC-01 expressed under iron limitation and oxidative stress conditions S Ghosh, C Dureja, I Khatri, S Subramanian, S Raychaudhuri, S Ghosh Microbiology 163 (12), 1924-1936, 2017 | 16 | 2017 |
| Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response TA Eubank, C Dureja, KW Garey, JG Hurdle, AJ Gonzales-Luna Clinical Infectious Diseases 79 (1), 15-21, 2024 | 7 | 2024 |
| Evidence of a new metabolic capacity in an emerging diarrheal pathogen: lessons from the draft genomes of Vibrio fluvialis strains PG41 and I21563 I Khatri, S Mahajan, C Dureja, S Subramanian, S Raychaudhuri Gut pathogens 5, 1-7, 2013 | 7 | 2013 |
| Alanine-scanning mutagenesis of WH2 domains of VopF reveals residues important for conferring lethality in a Saccharomyces cerevisiae model R Tripathi, V Kaithwas, C Dureja, S Raychaudhuri Gene 525 (1), 116-123, 2013 | 7 | 2013 |
| Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States AJ Gonzales-Luna, C Dureja, TA Eubank, KW Garey, JG Hurdle Clinical Infectious Diseases 76 (11), 2038-2039, 2023 | 4 | 2023 |
| Draft genome sequence of the opportunistic human pathogen Morganella morganii SC01 I Khatri, C Dureja, S Raychaudhuri, S Subramanian Genome announcements 1 (1), 10.1128/genomea. 00051-12, 2013 | 4 | 2013 |
| Indigo production goes green: a review on opportunities and challenges of fermentative production N Chandel, BB Singh, C Dureja, YH Yang, SK Bhatia World Journal of Microbiology and Biotechnology 40 (2), 62, 2024 | 3 | 2024 |
| Synthesis and evaluation of phenylimidazole FabK inhibitors as new Anti-C. Difficile agents K Norseeda, FBA Pavel, JT Rutherford, HN Meer, C Dureja, JG Hurdle, ... Bioorganic & medicinal chemistry 88, 117330, 2023 | 3 | 2023 |
| In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy C Dureja, JT Rutherford, FBA Pavel, K Norseeda, I Prah, D Sun, ... Antimicrobial Agents and Chemotherapy 68 (3), e01222-23, 2024 | 2 | 2024 |
| Alanine-scanning mutagenesis of selected residues in the N-terminal region alters the functionality of LuxO: lessons from a natural variant LuxOPL91 M Dongre, N Khatri, C Dureja, S Raychaudhuri Journal of medical microbiology 60 (6), 856-860, 2011 | 2 | 2011 |
| Evaluation of Fusobacterium nucleatum Enoyl-ACP Reductase (FabK) as a Narrow-Spectrum Drug Target JT Rutherford, K Avad, C Dureja, K Norseeda, B Gc, C Wu, D Sun, ... ACS Infectious Diseases 10 (5), 1612-1623, 2024 | 1 | 2024 |
| Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes TA Eubank, C Dureja, AJ Gonzales-Luna, JG Hurdle, KW Garey Open Forum Infectious Diseases 11 (11), ofae588, 2024 | | 2024 |
| Identification of critical amino acids in the DNA binding domain of LuxO: Lessons from a constitutive active LuxO S Surin, R Singh, M Kaur, GB Choudhury, H Sen, C Dureja, S Datta, ... Plos one 19 (9), e0310444, 2024 | | 2024 |
Saumya RaychaudhuriChief Scientist Institute of Microbial TechnologyBestätigte E-Mail-Adresse bei imtech.res.in